These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1656104)

  • 1. The influence of arachidonic acid metabolites on leukocyte activation and skeletal muscle injury after ischemia and reperfusion.
    Cambria RA; Anderson RJ; Dikdan G; Lysz TW; Hobson RW
    J Vasc Surg; 1991 Oct; 14(4):549-56. PubMed ID: 1656104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboxane synthetase inhibition decreases polymorphonuclear leukocyte activation following hindlimb ischemia.
    Cambria RA; Anderson RJ; Dikdan G; Lysz TW; Hobson RW II
    Am Surg; 1991 Feb; 57(2):76-9. PubMed ID: 1847027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1 and thromboxane release after skeletal muscle ischemia and reperfusion.
    Ascer E; Mohan C; Gennaro M; Cupo S
    Ann Vasc Surg; 1992 Jan; 6(1):69-73. PubMed ID: 1547081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte activation in ischemia-reperfusion injury of skeletal muscle.
    Cambria RA; Anderson RJ; Dikdan G; Teehan EP; Hernandez-Maldonado JJ; Hobson RW
    J Surg Res; 1991 Jul; 51(1):13-7. PubMed ID: 2067353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does iloprost mediate thromboxane activity and polymorphonuclear leukocyte sequestration in ischemic skeletal muscle?
    Mohan CR; Ascer E; Marini CP; Maughan RE; Gennaro M
    J Cardiovasc Surg (Torino); 1992; 33(5):613-8. PubMed ID: 1280271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postischemic renal injury is mediated by neutrophils and leukotrienes.
    Klausner JM; Paterson IS; Goldman G; Kobzik L; Rodzen C; Lawrence R; Valeri CR; Shepro D; Hechtman HB
    Am J Physiol; 1989 May; 256(5 Pt 2):F794-802. PubMed ID: 2541628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protective effect of thromboxane A2 synthetase inhibitor against ischemic liver injury.
    Isozaki H; Okajima K; Hara H; Kobayashi M
    Surg Today; 1994; 24(5):435-40. PubMed ID: 8054815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemia-reperfusion injury in myocutaneous flaps: role of leukocytes and leukotrienes.
    Kirschner RE; Fyfe BS; Hoffman LA; Chiao JJ; Davis JM; Fantini GA
    Plast Reconstr Surg; 1997 May; 99(6):1485-93; discussion 1494-5. PubMed ID: 9145114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of FK3311 on pulmonary ischemia-reperfusion injury in a canine model.
    Sunose Y; Takeyoshi I; Tsutsumi H; Kawata K; Tokumine M; Iwazaki S; Tomizawa N; Ohwada S; Matsumoto K; Morishita Y
    J Surg Res; 2001 Feb; 95(2):167-73. PubMed ID: 11162041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superoxide anion production by leukocytes exposed to post-ischemic skeletal muscle.
    Hernández-Maldonado JJ; Teehan E; Franco CD; Durán WN; Hobson RW
    J Cardiovasc Surg (Torino); 1992; 33(6):695-9. PubMed ID: 1337545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboxane mediates the ischemia-induced neutrophil oxidative burst.
    Paterson IS; Klausner JM; Goldman G; Kobzik L; Welbourn R; Valeri CR; Shepro D; Hechtman HB
    Surgery; 1989 Aug; 106(2):224-9. PubMed ID: 2527418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfluorocarbon emulsion prevents eicoasanoid release in skeletal muscle ischemia and reperfusion.
    Gennaro M; Mohan C; Ascer E
    Cardiovasc Surg; 1996 Jun; 4(3):399-404. PubMed ID: 8782946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limb ischemia-induced increase in permeability is mediated by leukocytes and leukotrienes.
    Klausner JM; Paterson IS; Valeri CR; Shepro D; Hechtman HB
    Ann Surg; 1988 Dec; 208(6):755-60. PubMed ID: 3196098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemia-induced neutrophil activation and diapedesis is lipoxygenase dependent.
    Goldman G; Welbourn R; Paterson IS; Klausner JM; Kobzik L; Valeri CR; Shepro D; Hechtman HB
    Surgery; 1990 Apr; 107(4):428-33. PubMed ID: 2157300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do cytokines play a role in skeletal muscle ischemia and reperfusion?
    Ascer E; Gennaro M; Cupo S; Mohan C
    J Cardiovasc Surg (Torino); 1992; 33(5):588-92. PubMed ID: 1447279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high plasma prostaglandin to thromboxane ratio protects against renal ischemia.
    Kaufman RP; Anner H; Kobzik L; Valeri CR; Shepro D; Hechtman HB
    Surg Gynecol Obstet; 1987 Nov; 165(5):404-9. PubMed ID: 3672299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value and limitation of iloprost infusion in decreasing skeletal muscle necrosis.
    Mohan C; Marini C; Gennaro M; Ascer E
    J Vasc Surg; 1992 Aug; 16(2):268-73. PubMed ID: 1379647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the thromboxane A2 synthetase inhibitor OKY-046 in a warm ischemia-reperfusion rat model.
    Garvin PJ; Niehoff ML; Robinson SM; Heisler T; Salinas-Madrigal L; Contis J; Solomon H
    Transplantation; 1996 May; 61(10):1429-34. PubMed ID: 8633364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the beta-blocker therapy on neutrophil superoxide generation and platelet aggregation in experimental myocardial ischemia and reflow.
    Röth E; Matos G; Guarnieri C; Papp B; Varga J
    Acta Physiol Hung; 1995; 83(2):163-70. PubMed ID: 8588503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.